ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.175,21
1,01%
S&P 500
5.180,74
1,03%
Dow Jones
38.852,27
0,46%
Euro vs US Dollar
1,07665
-0,01%
Bitcoin
63.442,46
0,44%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Century Therapeutics Inc (IPSC)

  7. Century Therapeutics Inc (IPSC) News

IPSC

Century Therapeutics (IPSC)

Century Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:IPSC
DatumZeitQuelleÜberschriftSymbolFirma
06/05/202422h52Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IPSCCentury Therapeutics Inc
23/04/202413h00GlobeNewswire Inc.Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing SummitNASDAQ:IPSCCentury Therapeutics Inc
11/04/202413h00GlobeNewswire Inc.Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade TherapeuticsNASDAQ:IPSCCentury Therapeutics Inc
08/04/202422h05GlobeNewswire Inc.Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:IPSCCentury Therapeutics Inc
25/03/202412h00GlobeNewswire Inc.Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of DirectorsNASDAQ:IPSCCentury Therapeutics Inc
19/03/202412h00GlobeNewswire Inc.Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual ConferenceNASDAQ:IPSCCentury Therapeutics Inc
14/03/202412h30GlobeNewswire Inc.Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business UpdatesNASDAQ:IPSCCentury Therapeutics Inc
09/03/202400h29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
07/03/202422h40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IPSCCentury Therapeutics Inc
06/03/202422h19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IPSCCentury Therapeutics Inc
06/03/202400h03GlobeNewswire Inc.Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:IPSCCentury Therapeutics Inc
21/02/202422h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
21/02/202419h04Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:IPSCCentury Therapeutics Inc
16/02/202422h18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IPSCCentury Therapeutics Inc
07/02/202423h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
07/02/202423h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
06/02/202422h25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IPSCCentury Therapeutics Inc
05/02/202421h23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IPSCCentury Therapeutics Inc
01/02/202413h00GlobeNewswire Inc.Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:IPSCCentury Therapeutics Inc
19/01/202423h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IPSCCentury Therapeutics Inc
11/12/202316h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IPSCCentury Therapeutics Inc
09/12/202318h00GlobeNewswire Inc.Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ EditsNASDAQ:IPSCCentury Therapeutics Inc
06/12/202322h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
06/12/202322h06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
06/12/202313h46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IPSCCentury Therapeutics Inc
06/12/202313h30GlobeNewswire Inc.Century Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data from Phase 1 ELiPSE-1 trial of CNTY-101 in Relapsed or Refractory B-cell Lymphomas and Planned Phase 1 Study in Systemic Lupus ErythematosusNASDAQ:IPSCCentury Therapeutics Inc
06/12/202313h30GlobeNewswire Inc.Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus ErythematosusNASDAQ:IPSCCentury Therapeutics Inc
21/11/202313h00GlobeNewswire Inc.Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:IPSCCentury Therapeutics Inc
09/11/202313h56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IPSCCentury Therapeutics Inc
09/11/202313h01GlobeNewswire Inc.Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:IPSCCentury Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:IPSC

Kürzlich von Ihnen besucht

AMEX
XLE
Energy Select Sector SPDR
TG
MBG
MercedesBenz
TG
BAS
BASF
AMEX
XLV
Health Care Select Sector
DBI
DAX
DAX
NASDAQ
GOOGL
Alphabet
TG
TUI1
Tui
COIN
ETHUSD
Ethereum
TG
DBK
Deutsche Bank
DBI
TDXP
Tec DAX
NASDAQ
AMZN
Amazon.com
NASDAQ
MSFT
Microsoft
NYSE
DIS
Walt Disney
NYSE
KO
Coca Cola
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten